Skip to main content
Log in

Nach Strahlentherapie und anthrazyklinhaltiger Chemotherapie

Wie groß ist das Risiko für eine Herzinsuffizienz bei Patienten mit Hodgkin-Lymphom?

  • journal club
  • Published:
InFo Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. van Nimwegen FA et al. Blood. 2017;129(16):2257–65.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Girinsky T et al. Radiother Oncol. 2006;79(3):270–7.

    Article  PubMed  Google Scholar 

  3. Eich HT et al. Strahlenther Onkol. 2008;184(8):406–10.

    Article  PubMed  Google Scholar 

  4. Specht L et al. Int J Radiat Oncol Biol Phys. 2014;89(4):854–62.

    Article  PubMed  Google Scholar 

  5. Maraldo MV et al. Int J Radiat Oncol Biol Phys. 2012;83(4):1232–7.

    Article  PubMed  Google Scholar 

  6. Nieder C et al. Radiother Oncol. 2007;82(3):301–7.

    Article  PubMed  Google Scholar 

  7. Girinsky T et al. Int J Radiat Oncol Biol Phys. 2006;64(1):218–26.

    Article  PubMed  Google Scholar 

  8. Hoppe BS et al. Int J Radiat Oncol Biol Phys. 2012;84(2):449–55.

    Article  PubMed  Google Scholar 

  9. Kriz J et al. Strahlenther Onkol. 2015;191(9):717–25.

    Article  PubMed  Google Scholar 

Originalie

  • van Nimwegen FA et al. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines. Blood. 2017;129(16):2257–65.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jan Kriz.

Additional information

Erstpubliziert in Strahlenther Onkol. 2017;193(8):677-8.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kriz, J., Eich, H.T. Wie groß ist das Risiko für eine Herzinsuffizienz bei Patienten mit Hodgkin-Lymphom?. Info Onkol. 20, 19–20 (2017). https://doi.org/10.1007/s15004-017-5845-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-017-5845-y

Schlüsselwörter

Navigation